Sequenom, Inc. Updates Second Half 2015 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Sequenom, Inc. Updates Second Half 2015 Revenue Outlook
September 29, 2015 7:17 AM EDT
Ladenburg Thalmann downgraded Sequenom (NASDAQ: SQNM) from Neutral to Sell.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $1.92 yesterday.
...
More
September 29, 2015 7:02 AM EDT
William Blair downgraded Sequenom (NASDAQ: SQNM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sequenom click here. For more ratings news on Sequenom click here.
Shares of Sequenom closed at $1.92 yesterday.
...
More
September 25, 2015 7:06 AM EDT
Sequenom (NASDAQ: SQNM) is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million. This versus the consensus of $141 million.
Drivers for the updated expectations include increased competition and price... More
September 25, 2015 7:05 AM EDT
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, provides its current revenue outlook for the second half of 2015.
The Company is updating its revenue expectations for the second half of the year to a range between $57 million and $61 million, bringing 2015 annual revenue... More
